Sinopharm Co., Ltd. released its report for the first quarter of 2024. Net profit attributable to mother for the first quarter was 459 million yuan, an increase of 10.86% over the previous year.
国药股份：第一季度归母净利润4.59亿元，同比增长10.86%
Sinopharm shares: net profit of 459 million yuan in the first quarter, up 10.86% year on year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.